Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity

Abstract Background Peripheral blood‐derived natural killer (NK) cells spontaneously lyse tumor cells without prior sensitization. However, NK cells in peripheral blood (PBNK cells) are in a resting state and exhibit inhibitory phenotypes and impaired cytotoxicity. Thus, strengthening the cytotoxic...

Full description

Saved in:
Bibliographic Details
Main Authors: Chuanling Liu, Yingying Li, Yanrong Li, Meng Hu, Haiyan Wang, Shasha Lu, Zhao Li, Dilinuer Dilimulati, Shunchang Jiao, Shelian Lu, Weihong Zhao
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.1143
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849473298784583680
author Chuanling Liu
Yingying Li
Yanrong Li
Meng Hu
Haiyan Wang
Shasha Lu
Zhao Li
Dilinuer Dilimulati
Shunchang Jiao
Shelian Lu
Weihong Zhao
author_facet Chuanling Liu
Yingying Li
Yanrong Li
Meng Hu
Haiyan Wang
Shasha Lu
Zhao Li
Dilinuer Dilimulati
Shunchang Jiao
Shelian Lu
Weihong Zhao
author_sort Chuanling Liu
collection DOAJ
description Abstract Background Peripheral blood‐derived natural killer (NK) cells spontaneously lyse tumor cells without prior sensitization. However, NK cells in peripheral blood (PBNK cells) are in a resting state and exhibit inhibitory phenotypes and impaired cytotoxicity. Thus, strengthening the cytotoxic effector function of PBNK cells and improving NK cell expansion in vitro for a convenient allogeneic therapy are essential. Materials and Methods Pure cytokine activation and expansion of NK cells (super NK [SNK]) from peripheral blood mononuclear cells were studied. Markers of activated and inhibited NK cells and cytokine secretion by NK cells were examined using flow cytometry. NK cell antitumor activity in vitro was assessed using lactate dehydrogenase (LDH) cytotoxicity assay and an Incucyte real‐time imaging system. Additionally, the function of SNK cells against ascites caused by ovarian cancer in NOD‐Prkdc(em26Cd52)il2rg(em26Cd22)/Nju (NCG) mice was determined. In a further investigation of the differences between PBNK and SNK, the mRNA of both cells was sequenced and analyzed. Results Human peripheral blood mononuclear cells showed selective NK cell expansion upon cytokine activation and culture. Both SNK and PBNK cells expressed activation markers, but at different levels, and SNK cells secreted more cytokines related to cytotoxicity than PBNK cells did. Accordingly, SNK cells exhibited strong antitumor activity ex vivo and improved NCG mice survival after intraperitoneal ovarian cancer transplantation. Mechanistically, SNK cells expressed more genes associated with nucleotide metabolism, fatty acid, and ATP metabolism than PBNK cells. Conclusion SNK cells derived from peripheral blood mononuclear cells have sufficiently activated mature characteristics and high antitumor activity, rendering them a highly promising and essential therapeutic approach for cancer treatment.
format Article
id doaj-art-5ad9560eed704061b8c5cb1c3f2ea43e
institution Kabale University
issn 2050-4527
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Immunity, Inflammation and Disease
spelling doaj-art-5ad9560eed704061b8c5cb1c3f2ea43e2025-08-20T03:24:11ZengWileyImmunity, Inflammation and Disease2050-45272024-01-01121n/an/a10.1002/iid3.1143Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activityChuanling Liu0Yingying Li1Yanrong Li2Meng Hu3Haiyan Wang4Shasha Lu5Zhao Li6Dilinuer Dilimulati7Shunchang Jiao8Shelian Lu9Weihong Zhao10Department of Oncology Chinese PLA General Hospital Beijing ChinaResearch and Development Department Beijing DCTY® Biotech Co., Ltd Beijing ChinaResearch and Development Department Beijing DCTY® Biotech Co., Ltd Beijing ChinaResearch and Development Department Beijing DCTY® Biotech Co., Ltd Beijing ChinaResearch and Development Department Beijing DCTY® Biotech Co., Ltd Beijing ChinaResearch and Development Department Beijing DCTY® Biotech Co., Ltd Beijing ChinaResearch and Development Department Beijing DCTY® Biotech Co., Ltd Beijing ChinaResearch and Development Department Beijing DCTY® Biotech Co., Ltd Beijing ChinaDepartment of Oncology Chinese PLA General Hospital Beijing ChinaResearch and Development Department Beijing DCTY® Biotech Co., Ltd Beijing ChinaDepartment of Oncology Chinese PLA General Hospital Beijing ChinaAbstract Background Peripheral blood‐derived natural killer (NK) cells spontaneously lyse tumor cells without prior sensitization. However, NK cells in peripheral blood (PBNK cells) are in a resting state and exhibit inhibitory phenotypes and impaired cytotoxicity. Thus, strengthening the cytotoxic effector function of PBNK cells and improving NK cell expansion in vitro for a convenient allogeneic therapy are essential. Materials and Methods Pure cytokine activation and expansion of NK cells (super NK [SNK]) from peripheral blood mononuclear cells were studied. Markers of activated and inhibited NK cells and cytokine secretion by NK cells were examined using flow cytometry. NK cell antitumor activity in vitro was assessed using lactate dehydrogenase (LDH) cytotoxicity assay and an Incucyte real‐time imaging system. Additionally, the function of SNK cells against ascites caused by ovarian cancer in NOD‐Prkdc(em26Cd52)il2rg(em26Cd22)/Nju (NCG) mice was determined. In a further investigation of the differences between PBNK and SNK, the mRNA of both cells was sequenced and analyzed. Results Human peripheral blood mononuclear cells showed selective NK cell expansion upon cytokine activation and culture. Both SNK and PBNK cells expressed activation markers, but at different levels, and SNK cells secreted more cytokines related to cytotoxicity than PBNK cells did. Accordingly, SNK cells exhibited strong antitumor activity ex vivo and improved NCG mice survival after intraperitoneal ovarian cancer transplantation. Mechanistically, SNK cells expressed more genes associated with nucleotide metabolism, fatty acid, and ATP metabolism than PBNK cells. Conclusion SNK cells derived from peripheral blood mononuclear cells have sufficiently activated mature characteristics and high antitumor activity, rendering them a highly promising and essential therapeutic approach for cancer treatment.https://doi.org/10.1002/iid3.1143ascitesnatural killer cellovarian cancerperipheral blood
spellingShingle Chuanling Liu
Yingying Li
Yanrong Li
Meng Hu
Haiyan Wang
Shasha Lu
Zhao Li
Dilinuer Dilimulati
Shunchang Jiao
Shelian Lu
Weihong Zhao
Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity
Immunity, Inflammation and Disease
ascites
natural killer cell
ovarian cancer
peripheral blood
title Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity
title_full Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity
title_fullStr Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity
title_full_unstemmed Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity
title_short Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity
title_sort sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity
topic ascites
natural killer cell
ovarian cancer
peripheral blood
url https://doi.org/10.1002/iid3.1143
work_keys_str_mv AT chuanlingliu sufficientlyactivatedmaturenaturalkillercellsderivedfromperipheralbloodmononuclearcellssubstantiallyenhanceantitumoractivity
AT yingyingli sufficientlyactivatedmaturenaturalkillercellsderivedfromperipheralbloodmononuclearcellssubstantiallyenhanceantitumoractivity
AT yanrongli sufficientlyactivatedmaturenaturalkillercellsderivedfromperipheralbloodmononuclearcellssubstantiallyenhanceantitumoractivity
AT menghu sufficientlyactivatedmaturenaturalkillercellsderivedfromperipheralbloodmononuclearcellssubstantiallyenhanceantitumoractivity
AT haiyanwang sufficientlyactivatedmaturenaturalkillercellsderivedfromperipheralbloodmononuclearcellssubstantiallyenhanceantitumoractivity
AT shashalu sufficientlyactivatedmaturenaturalkillercellsderivedfromperipheralbloodmononuclearcellssubstantiallyenhanceantitumoractivity
AT zhaoli sufficientlyactivatedmaturenaturalkillercellsderivedfromperipheralbloodmononuclearcellssubstantiallyenhanceantitumoractivity
AT dilinuerdilimulati sufficientlyactivatedmaturenaturalkillercellsderivedfromperipheralbloodmononuclearcellssubstantiallyenhanceantitumoractivity
AT shunchangjiao sufficientlyactivatedmaturenaturalkillercellsderivedfromperipheralbloodmononuclearcellssubstantiallyenhanceantitumoractivity
AT shelianlu sufficientlyactivatedmaturenaturalkillercellsderivedfromperipheralbloodmononuclearcellssubstantiallyenhanceantitumoractivity
AT weihongzhao sufficientlyactivatedmaturenaturalkillercellsderivedfromperipheralbloodmononuclearcellssubstantiallyenhanceantitumoractivity